WallStSmart
LUCD

Lucid Diagnostics Inc

NASDAQ: LUCD · HEALTHCARE · MEDICAL DEVICES

$1.07
+3.88% today

Updated 2026-04-30

Market cap
$199.66M
P/E ratio
—
P/S ratio
42.43x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Lucid Diagnostics Inc (LUCD) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item20182019202020212022202320242025
Revenue—$0.00$0.00$500000.00$377000.00$2.43M$4.35M$4.71M
Revenue growth (YoY)————-24.6%+544.0%+79.0%+8.3%
Cost of revenue——$0.00$585000.00$3.61M$8.48M$8.27M$7.54M
Gross profit——$0.00$-85000.00$-3.24M$-6.05M$-3.92M$-2.84M
Gross margin———-17.0%-858.6%-249.2%-90.2%-60.3%
R&D$715629.00$3.46M$5.44M$9.30M$11.47M$7.25M$5.99M$5.68B
SG&A$615428.00$958722.00$2.84M$12.78M$23.68M$19.25M$20.16B$23.87B
Operating income$-1.13M$-4.42M$-8.28M$-27.42M$-56.17M$-48.48M$-46.05M$-49.64M
Operating margin———-5483.8%-14899.5%-1996.8%-1059.6%-1054.8%
EBITDA$562957.00$-4.42M$-8.28M$-27.41M$-54.23M$-49.75M$-44.34M$-48.77M
EBITDA margin———-5483.0%-14385.9%-2049.1%-1020.2%-1036.3%
EBIT$-1.13M$-4.42M$-8.28M$-27.42M$-56.17M$-52.25M$-45.50M$-49.64M
Interest expense$0.00$0.00$0.00$659000.00$8000.00$416000.00$26000.00$22000.00
Income tax$-1.69M$-4.42M$-8.28M$659000.00$1.71M$2.33M$7.50B—
Effective tax rate60.0%50.0%50.0%-2.4%-3.1%-4.6%100.6%0.0%
Net income$-1.13M$-4.42M$-8.28M$-28.08M$-56.17M$-52.67M$-45.53M$-58.01M
Net income growth (YoY)—-292.6%-87.3%-239.1%-100.1%+6.2%+13.6%-27.4%
Profit margin———-5615.6%-14899.5%-2169.1%-1047.6%-1232.7%